AURKA PHARMA

aurka-pharma-logo

AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans to begin clinical development in Q3-2017. Once cleared for clinical development by regulatory authorities, the it compound will be tested directly alone in solid tumors. Later on, the compound may be tested in one of a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.

#SimilarOrganizations #People #Financial #Website #More

AURKA PHARMA

Industry:
Biotechnology Medical Medical Device Pharmaceutical

Founded:
2016-01-01

Address:
Montrรฉal, Quebec, Canada

Country:
Canada

Website Url:
http://www.aurkapharma.com

Total Employee:
11+

Status:
Active


Similar Organizations

advanced-bioenergy-logo

Advanced BioEnergy

Advanced BioEnergy is a liability company formed to develop, construct, own, and operate ethanol plants and other biofuels businesses.

alera-labs-logo

Alera Labs

Alera Labs is a contract research company that provides discovery and development services to medical devices.

automation-validation-solutions-logo

Automation & Validation Solutions

Automation & Validation Solutions is committed to going beyond the solution by building strong connections.

esperas-pharma-logo

Esperas Pharma

Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.

Current Employees Featured

caroline-fortier_image

Caroline Fortier
Caroline Fortier CEO @ AurKa Pharma
CEO

Investors List

tvm-capital-life-science_image

TVM Capital Life Science

TVM Capital Life Science investment in Venture Round - AurKa Pharma

Official Site Inspections

http://www.aurkapharma.com

  • Host name: 57.221.168.184.host.secureserver.net
  • IP address: 184.168.221.57
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "AurKa Pharma"

AurKa Pharma - Crunchbase Company Profile & Funding

AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans โ€ฆSee details»

Aurka Pharma Company Profile 2024: Valuation, Investors

Aurka Pharma General Information Description. Developer of one compound proof-of-concept drug designed to treat tumors. The company's drug are developed mainly to focus on the โ€ฆSee details»

AurKa Pharma - Ownership and Business Overview - Mergr

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018.The largest life science acquisition in 2018 was Shire - which was acquired by Takeda โ€ฆSee details»

AurKa Pharma Inc - Company Profile and News - Bloomberg Markets

Company profile page for AurKa Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»

AurKa Pharma Company Profile | Management and Employees List โ€ฆ

Find contact information for AurKa Pharma. Learn about their Accounting Services, Business Services market share, competitors, and AurKa Pharma's email format.See details»

AurKa Pharma - Overview, News & Similar companies - ZoomInfo

AurKa Pharma's headquarters are located at 1255 Boul. Robert Bourassa Bureau 1610, Montreal, Quebec, H3B 3X3, Canada What is AurKa Pharma's official website?See details»

Lilly to buy cancer drug developer AurKa Pharma

Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora โ€ฆSee details»

AurKa Pharma - Products, Competitors, Financials, Employees ...

AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. Use the CB Insights Platform to explore AurKa Pharma's full profile.See details»

AurKa Pharma CEO, Founder, Key Executive Team, Board of โ€ฆ

Explore {AurKa Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Organization | AurKa Pharma Inc. - CDEK

Organization Overview. First Clinical Trial. 2017 NCT03092934. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2017 Timeline < Back; View all... NOW. Now; Active โ€ฆSee details»

Eli Lilly announces its plans to acquire AurKa Pharma

May 17, 2020 Eli Lilly has revealed its agreement to acquire AurKa Pharma, Inc. Established by TVM Capital Life Science, the company has developed oncology compound AK-01, an Aurora โ€ฆSee details»

Lilly to buy Canadaโ€™s AurKa Pharma for $110m

Eli Lilly corporate business development senior vice-president Darren Carroll said: โ€œThe acquisition of AurKa Pharma supports Lillyโ€™s external innovation strategy, in which we seek to โ€ฆSee details»

Lilly to Acquire AurKa Pharma in Deal Worth Up to $575 million

On May 14, 2018, Eli Lilly announced an agreement to acquire AurKa Pharma, a company established by TVM Capital Life Science to develop an oncology compound, in a deal worth up โ€ฆSee details»

Lilly to Acquire AurKa Pharma - American Pharmaceutical Review

May 18, 2018 Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an โ€ฆSee details»

Lilly to acquire AurKa Pharma in $575m deal

May 15, 2018 AurKa Pharma was established as part of the TVM Life Science Ventures VII fund, to develop an Aurora kinase A inhibitor called AK-01. The oncology compound was discovered โ€ฆSee details»

Lilly acquires AurKa | C&EN Global Enterprise - ACS Publications

Eli Lilly & Co. is expanding its cancer drug pipeline by buying back a compound it sold to TVM Capital Life Science in 2016. TVM founded AurKa Pharma to develop the compound, AK-01, โ€ฆSee details»

AURA PHARMACEUTICALS PRIVATE LIMITED - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for AURA PHARMACEUTICALS PRIVATE LIMITED of Mumbai, Maharashtra. Get the latest business โ€ฆSee details»

Aura Pharma - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 55 800-444-0000 Aura Pharma is a pharmaceutical company that specializes in the production and distribution of a wide range of โ€ฆSee details»

Aura Pharmaceuticals - Corporate Social Responsibility

As a global organization, we are aware of the fact that people devote a large part of their productive life with us, and also, that we utilise many resources from the society and the โ€ฆSee details»

Auro Pharma Canada

Subsidiary of Aurobindo Pharma Auro Pharma, a Canadian subsidiary of Aurobindo Pharma Ltd.. Aurobindo Pharma is a vertically integrated pharmaceutical organization heavily focused in โ€ฆSee details»

linkstock.net © 2022. All rights reserved